# Morningside Capital

> Morningside Capital is a VC fund backing Biotechnology and Semiconductor. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Chicago, United States
- Total investments: 4
- Last investment: Aug 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/morningside-capital

Morningside Capital is a venture capital and private equity company that specializes in early-stage investing. The company seeks to move the human race forward by empowering the ideas of entrepreneurs and inventors.

## Contacts

5 contacts available for Morningside Capital. Shizune tracks 1 team members at Morningside Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/morningside-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 25% |
| Semiconductor | 1 | 25% |
| Pharmaceutical | 1 | 25% |
| Packaging Services | 1 | 25% |
| Artificial Intelligence | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Angel | 1 | 25% |
| Series C | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 2 | 50% |
| United States | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Thomas Kim | Principal | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xinde Semiconductor | Xinde Semiconductor offers services for semiconductor packaging and testing. It offers clients turnkey high-tech mid- and back-end packaging and testing services, with a focus on mobile products. |  | Series A | Aug 01, 2021 |  |
| Xinde Semiconductor | Xinde Semiconductor offers services for semiconductor packaging and testing. It offers clients turnkey high-tech mid- and back-end packaging and testing services, with a focus on mobile products. |  | Angel | Jan 01, 2021 |  |
| XtalPi | XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enablespharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since grown into an elite team of researchers with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D, and algorithm design. XtalPi has received much recognition for its cutting-edge technologies, its innovative solutions, and the breadth of potential applications of its offerings across the pharmaceutical value chain, which has allowed it to gain industry approval and establish strategic partnerships with several top international pharmaceutical companies. | $318.8M | Series C | Sep 28, 2020 |  |
| Innolife | Finance |  | Series A | Jan 06, 2018 |  |

4 of 4 investments shown.

## Co-investors
- [CITIC Capital Holdings](https://shizune.co/investors/profile/citic-capital-holdings) — VC Fund, 1 deal together
- [CMB International's Telecom Fund.](https://shizune.co/investors/profile/cmb-international-s-telecom-fund) — VC Fund, 1 deal together
- Guoce Group — VC Fund, 1 deal together
- [Guotou Chuangying](https://shizune.co/investors/profile/guotou-chuangying) — VC Fund, 1 deal together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 1 deal together
- Huatai New Industry Fund — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Morningside Capital invest in?

Morningside Capital invests primarily in Biotechnology, Semiconductor and Pharmaceutical startups, most often at Series A and Angel stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Morningside Capital?

Public channels for Morningside Capital include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Morningside Capital?

The team at Morningside Capital includes Thomas Kim (Principal). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co